In patients with tuberculous meningitis, high-dose rifampin yields no survival advantage over the standard dose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback